Conference - Washington, District of Columbia, United States
Technologies and Strategies for Safe and Efficacious Products in the Clinic
Get ready to join 300+ of your peers on November 11-13, 2013 in Washington, DC at the Number 1 Immunogenicity Summit in the U.S. CHI has an established reputation as a global education provider on immunogenicity. Our 2013 summit will build on last year’s successful event. With double the number of tracks this year, the Immunogenicity Summit 2013 presents technologies for safety and efficacy from bench to bedside. For early stage decision making on drug design and optimization, we examine the causes of immunogenicity together with means of mitigation, and present PK/PD and bioassay strategies. For later pre-clinical and clinical stages, we examine the complexities of immunogenicity assays, bioassays and PK/PD development, and present risk assessment strategies for smooth interaction with the regulatory authorities, and safe and efficacious products in the clinic.
(Courtesy of logo of Immunogenicity Summit 2013, via immunogenicitysummit.com)
Sponsoring Institution: Cambridge Healthtech Institute
For more information, please visit: http://www.immunogenicitysummit.com
November 11, 2013 - November 13, 2013 (8:00 am - 4:00 pm)
Hyatt Regency on Capitol Hill, Washington, DC 20001, USA
Contact: Kris Waterman (kwaterman@healthtech.com)
Phone: 781-972-5400
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
